Electrospun nanofibrous platforms for advanced biomedical applications: from tissue regeneration to localized and controlled drug delivery
Frontiers in Bioengineering and Biotechnology · 20.11.2026 · 14
DOI: 10.3389/fbioe.2026.1990141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 20.11.2026. Verfasst von Ze Luo und 3 weiteren Autor:innen. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Electrospinning has emerged as a powerful technique for fabricating nanofibrous materials with high surface area, tunable porosity, and extracellular matrix–like mechanical properties. These unique features have enabled its broad application in biomedicine, particularly in regenerative medicine, wound healing, and drug delivery. In tissue engineering, electrospun scaffolds provide favorable microenvironments that promote cell adhesion, proliferation, and differentiation, thereby supporting the regeneration of bone, nerve, and cardiac tissues. For wound healing, functionalized nanofibers incorporating antibacterial agents, growth factors, or bioactive molecules have been investigated for supporting tissue repair and modulating scar formation. In drug delivery, electrospinning enables modulation of release kinetics through control of fiber morphology and composition, supporting localized, sustained, or otherwise controlled delivery while potentially reducing systemic exposure. Its integration with stem cell technology and smart, responsive materials is further expanding its potential applications in personalized and precision medicine. Beyond the spinning process itself, coupling electrospinning with three-dimensional (3D) printing, spray-assisted deposition, and gas foaming makes it possible to combine nanofibrous cues with printed three-dimensional geometry and controlled macropores, which broadens the range of tissues and release profiles that can be addressed. Although scalability and clinical translation remain major challenges, these hybrid strategies are expanding the structural and functional design space of electrospun biomedical systems. This narrative review examines electrospinning principles, hybrid fabrication strategies, biomedical applications, and the barriers that currently limit clinical translation.
Zitieren
APA
Luo, Z., Li, H., Sun, D., & Cheng, F. (2026). Electrospun nanofibrous platforms for advanced biomedical applications: from tissue regeneration to localized and controlled drug delivery. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1990141
Vancouver
Luo Z, Li H, Sun D, Cheng F. Electrospun nanofibrous platforms for advanced biomedical applications: from tissue regeneration to localized and controlled drug delivery. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1990141
BibTeX
@article{Luo2026,
author = {Luo, Ze and Li, Hongbin and Sun, Dan and Cheng, Feng},
title = {Electrospun nanofibrous platforms for advanced biomedical applications: from tissue regeneration to localized and controlled drug delivery},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1990141}
}
EUVIMED